Clearmind Medicine Inc. is a psychedelic pharmaceutical biotech company. The Company is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The Company researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Companyโs intellectual portfolio consists of 19 patent families including 31 granted patents.
์ข
๋ชฉ ์ฝ๋ CMND
ํ์ฌ ์ด๋ฆClearmind Medicine Inc
์์ฅ์ผAug 10, 2021
CEOZuloff-Shani (Adi)
์ง์ ์- -
์ ํOrdinary Share
ํ๊ณ ์ฐ๋ ์ข
๋ฃAug 10
์ฃผ์101-1220 West 6Th Avenue
๋์VANCOUVER
์ฆ๊ถ ๊ฑฐ๋์NASDAQ OMX - NASDAQ BASIC
๊ตญ๊ฐCanada
์ฐํธ ๋ฒํธV6H 1A5
์ ํ16042601566
์น์ฌ์ดํธhttps://www.clearmindmedicine.com/
์ข
๋ชฉ ์ฝ๋ CMND
์์ฅ์ผAug 10, 2021
CEOZuloff-Shani (Adi)
์ง๋ 5๋
๋์ ์ด
0.00
USD์ ๋ฐฐ๋น๊ธ์ด ๋ถ๋ฐฐ๋์์ต๋๋ค.

๋ฐ์ดํฐ ์์